FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/16/2022
Back to search
Official data from USPTO
UPPLUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/16/2022
Trademark type
Word
Nice classes
5
Filing date
10/21/2020
Registration date
02/22/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/22/2022
Last transaction
02/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
RIBAUDO, MICHELLE
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
APEX BIOTECH RESEARCH PTY LTD
Representatives
Katherine P. Califa Foley & Lardner LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutritionally fortified herbal beverages for medicinal use; Nutritionally fortified medicated beverages; Nutritionally fortified medicinal beverages for medical purposes; Vitamin enriched sparkling water for medical purposes; Nutritionally fortified water for medical purposes; Vitamin enriched water for medical purposes; disinfectants for hygiene purposes; Medicated products for oral hygienemedicated toothpaste; Medicated mouthwash for oral hygiene purposes; Preparations for oral hygienemedicated toothpasteother than dentifrices; Preparations for personal hygienedisinfectants; Disinfectants for hygienic purposes; Acne treatment preparations in the form of cleansers; Acne treatment preparations in the form of creams; anti-bacterial pharmaceutical preparations; Chemical products for pharmaceutical use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Chemicals for pharmaceutical use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for animals for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for application to the skin for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for health care for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for human use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for nasal use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for oral use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for personal use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for topical use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for veterinary use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations in the form of emulsions for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations in the form of throat lozenges and medicated lozenges; pharmaceutical preparations in the form of tablets for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical products for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical products derived from natural sources for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical tonic preparations for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; plant extracts for pharmaceutical purposes; plant extracts for pharmaceutical use; Pharmaceutical preparations in the nature of plant extracts for pharmaceutical use; propolis for pharmaceutical purposes; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; medicated mouth spray; mouth sprays for medical use; Anti-inflammatory sprays for the body for medical use; sprays for use on the body namelymedicaments for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Acne treatment sprays for use on the body; medicated mouthwashes; medicated antiseptic mouthwashes; medical mouthwashes; mouthwashes and gargles for medical purposes; mouthwashes for medical purposes; eye drops; throat lozenges for pharmaceutical purposes; medicated throat lozenges; medical toothpastes; medicated toothpaste
Publications
History of USPTO decisions and trademark events.
24 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/27/2022
FIMP
FINAL DISPOSITION PROCESSED
07/27/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2021
PUBO
PUBLISHED FOR OPPOSITION
12/07/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/06/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/17/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2021
RFNT
REFUSAL PROCESSED BY IB
04/25/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/05/2021
RFRR
REFUSAL PROCESSED BY MPU
04/05/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/29/2021
CNRT
NON-FINAL ACTION WRITTEN
03/28/2021
DOCK
ASSIGNED TO EXAMINER
03/22/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/26/2020
Continuous trademark protection
Get notified about every new filing that threatens UPPLUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.